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Atriovenlricular (AV) node reentrant tachycardia is cer- 
tainly the most cnmman mechanism of paroxysmal su- 
praventricular tachycardia encountered in clinical prectice. 
In 1973 its electrophysiologic substrate was recognized to 
involve dual AV node pathways by Denes and others in the 
late Ken Rosen’s group (1). They described the presence of 
two tvoes of AH intervals in at&ted oatients: short AH 
inter& that were observed when test &al stimuli had long 
coupling intervals and long AH intervals that were seen with 
critically premature test atrial stimuli. These observations 
:ed to the concept of a fast pathway with a long refractory 
period and a slow pathway with a short refractory period, 
both capable of antemgmde (and sometimes retrograde) 
conduction through the AV junction. that is, duel AV node 
pathways. In the vast majority of patients with AV node 
reentrant tachycardia, the tachycardia circuit involves an- 
terograde slow pathway conduction and retrograde fast 
pathway conduction. 
Ablation therapy. Surgical (2-5) and catheter ablation 
techniques (6-8) for the modification of AV node conduction 
and cure of AV node reentrant techycardia have destroyed 
the dogma that the reentrant circuit in this tachycardia is 
confined to the AV node. Although there is still~plenly of 
argument as to how much of the p&o&d tissue should be 
considered part of the AV node, it is abundantly clear that 
the reentrant circuit no, only includes what is most cotwe~ 
niently termed the “compact AV node” but also has as a 
necessary component the inferior aspects of Koch’s triangle, 
especially along the tricuspid aoulus as low as the level ofthe 
ostium of the coronary sinus. Ablation therapy applied to 
these inferior approaches to the AV junction will selectively 
destroy or impair slow pathway conduction, whereas current 
delivered close to the compact AV node will selectively 
destroy or impair the fast pathway (which may or may not be 
the same as the compact AV node!). Although the first 
catheter ablations for AV node reentrant tachycardia were 
directed to selective ablation of the fast pathway, the man- 
ifest risk of inducing complete heart block when an ablation 
target is close to the compact AV node has led most workers 
to select slow pathway ablation as the thenpeutic procedure 
of choice. 
Catheter ablation therapy of AV node reentrant achycar- 
dia has a uniquely high success rate. When an aggressive 
strategy is employed, i. is virtually always possible to render 
AV node tachycardia wninducible whether the ablation site 
is chosen by anatomic-electmphysiologic landmarks (8,9) or 
by slow pathway potential recordings (IO). In fact, to elim- 
inate the clinical recwrence of AV node reentrant tacbycar- 
dia, it is not necessary for the ablation procedure to elimi- 
nate all evidence of slow pathway conduction or even to 
destroy the capacity of the slow pathway to conduct single 
echo beats (9,101, although in our own experience (II) the 
persistence of slow pathway conductior has been a risk 
factor for such clinical recurrence. 
Ptcscnt study. Wu et al. (12) in this issue of the Journal 
describe a modification of the anatomic-electraphysiologic 
approatn to selective slow pathway ablation whereby the 
target site for ablation is selected by first poritioniq the 
ablation catheter at the site recording the biggest proximal 
His bundle deflection and then turning the catheter tip down 
and toward the tricuspid amdus until ahe His deflection is no 
longer apparent and the local atrial electrogmm amplitude is 
smaller than the local ventricular electrogmm amplitude. 
They found that application of radiofrequency energy to this 
site was very successftd in ablating the induction of AV node 
reentrant tachywdia, usually by the selective ablation or 
modification of the slow pathway. Among the 100 patients 
who form the core of thei; report, slow pathway conduction 
was ablated or modified in 94 patients, counting the 12 
patients who had both anterogmde slow pathway and retro- 
grade fast pathway ablation but no1 counting the 3 patients 
with comolete heart block (who also no lower had eEective 
slow p&way conduction). The fast pathway was ablated or 
modified without effect on the slow pathway in three pa- 
tients. Wu et al. also update their series with a brief 
addendum that describes an additional 69 patients treated 
with the same approach, including ! additional patient who 
had heart block for several weeks. Several comments aboul 
this technique are appropriate. 
F?wdmRyoftbeablatiwsitetotbemmpactAVnode. The 
site identified as HB in Figure 2, where the maximal proxi- 
mai His deflection was recorded, is the site where radiofre- 
quency current is applied to deliberately ablate the AV node 
and induce complete heart block in patients with medically 
refractory at&l fibrillation. The technique as described by 
Wu el al. (12) would typically place the ablation ca~..elet 
closer to the compact AV node than is usuoUy necessary to 
selectively ablate the anterogtade slow pathway of AV node 
reentrant tachycardia. in our group’s experience (13) with 
252 patients undergoing radiofrequency ablation of AV node 
reentrant tachycardia, only about IS% of patients required 
energy application as close to the compact node as occurred 
routinely with the technique of Wu et al. This di6eereoce 
occurred even though our routine objective was total elimi- 
nation of aU evidence of residual slow pathway conduction. 
a more rigorous criterion for a successful end point of the 
ablation therapy than that in the series of Wu et al. In our 
series only three patients have developed complete heat 
block, in each ease as a consequence of a deliberate shit of 
the ablation target site from close to the corouary sinus 
ostium toward the compact AV node, the site targeted by 
Wu et al. .zs their primary site of ahiation thcrdpy. The 
tnaxm~ to remembe; is that the closer a lesion is to the 
comuact P.V node. !hc mc:e !ikelv that lesion is to create 
complete heart block. 
Overlap of sites that resulted iu slow veaws slow plus fast 
pathway ablation. In the study of Wu et al. there wus 
marked overlap in the sites af ablation that selectively 
ablated the slow pathway and sites that also resulted in 
ablation of the fast pathway. This overlap is to be expected 
whenall ablationsitesare relatively close tothecompact AV 
node. Jackman et al. (IO) cbsewed fast pathway ablation 
remote from the eompacl AV node in only one patient and in 
the OUT series (131, fast pathway ablation occurred remote 
from the compact AV node in only one patient. 
B a pcrmauent pwxmaker wxssary? Of the four patients 
who developed complete heat block, a permanent pace- 
maker was implanted in only one. apparently with no com- 
plications in the patients who did not receive a pacemaker. 
This intereStiog observation would be very difficult to con- 
hrm in the medical-legal climate of the United Stata but 
implies that the escape pacemaker is quite stable, at least for 
months at a time and that the decision to implant a penna- 
neut pacer in the event of the inadvertent production of heat? 
black cat be delayed for at least a few days to see whether 
AV conduction will roteturn. However, we have seen a patient 
with late. although asymptomatic, development of complete 
heart block; therefore. the early presetwttion of AV conduc- 
tion does uot mean that there is no late risk (8). 
lnfbrmed d&&t at&@. The need of patients for abla- 
tion of AV node reentrant tachycardia, and hence their 
willingness to risk complete heart block as a complication of 
the proeeduro, varies greatly. Although no oue can ahso. 
lutely guarantee that there will be no accidental dislodgment 
of R catheter during ablation with inadvertent creation of 
complete heart block. the risk of heart hloxk can be made 
4% by targeting only those ablation sites that are in the 
most inferior aspects of Koch’s triangle and by avoiding 
slow pathway ablation in the rare patient with inadequate 
anterograde fast pathway conduction. This means that Le 
phystcian and patient can and should make au informed 
decision about the aggressiveness of the ablation procedure 
in advance of the procedure, determining “what price suc- 
cesa?” on the b&s of ar. acceptable risk of wmo;ete heart 
block fw that &at. For mbst patients, eom&te heart 
block is too dear a price to pay for the ablatiou of AV o&e 
reentrant tachycardia. 
